JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cayen, M. N.
Right arrow Articles by Dvornik, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cayen, M. N.
Right arrow Articles by Dvornik, D.

Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs

MN Cayen, ES Ferdinandi, E Greselin, WT Robinson and D Dvornik

In rats, equimolar oral doses of [14C]clofibrate and [14c]clofibric acid produced essentially the same profiles of blood levels, tissue distribution and excretion of radioactivity. Both compounds were completely absorbed, and all radioactivity found in the serum was due to clofibric acid (CPIB). Tissues contained readily detectable radioactivity levels, but the concentration was generally lower than in serum. A large proportion of CPIB in liver, heart, kidney, fat and muscle was associated with intracellular space. In rat urine, CPIB was present both free and conjugated with glucuronic acid. Approximately 97% of the serum CPIB was not conjugated. Identical decreases in serum lipids and hepatic cholesterol synthesis were observed in rats treated for 1 week with either compound. In dogs, the serum contained 40% more radioactivity after [14C]clofibric acid than after an equimolar oral dose of [14C]clofibrate; approximately 88% of the serum radioactivity was due to CPIB. Some biliary excretion was detected. The extent of binding to serum protein varied with concentration of CPIB and with the species; the affinity was in the order man greater than dog greater than rat. The results demonstrate that clofibric acid and clofibrate are metabolically and pharmacologically equivalent in rats, but not in dogs. The data are in accordance with the view that the pharmacological activity of clofibrate is due to clofibric acid.

Volume 200, Issue 1, pp. 33-43, 01/01/1977
Copyright © 1977 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
C. Li, M. P. Grillo, I. Badagnani, K. L. Fife, and L. Z. Benet
Differential Effects of Fibrates on the Metabolic Activation of 2-Phenylpropionic Acid in Rats
Drug Metab. Dispos., April 1, 2008; 36(4): 682 - 687.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Michel, C. Desdouets, B. Sacre-Salem, J.-C. Gautier, R. Roberts, and E. Boitier
Liver Gene Expression Profiles of Rats Treated with Clofibric Acid: Comparison of Whole Liver and Laser Capture Microdissected Liver
Am. J. Pathol., December 1, 2003; 163(6): 2191 - 2199.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Matsuura, A. Hara, M. Kato, Y. Deyashiki, Y. Miyabe, S. Ishikura, T. Sugiyama, and Y. Katagiri
Activation of Human Liver 3alpha -Hydroxysteroid Dehydrogenase by Clofibrate Derivatives
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1096 - 1103.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics.